Fox Run Management, L.L.C. Royalty Pharma PLC Transaction History
Fox Run Management, L.L.C.
- $608 Million
- Q1 2025
A detailed history of Fox Run Management, L.L.C. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 20,646 shares of RPRX stock, worth $696,802. This represents 0.11% of its overall portfolio holdings.
Number of Shares
20,646
Previous 55,062
62.5%
Holding current value
$696,802
Previous $1.4 Million
54.27%
% of portfolio
0.11%
Previous 0.27%
Shares
12 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.38 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.24 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$777 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$452 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$411 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...